ANANTH ANNAPRAGADA to Alzheimer Disease
This is a "connection" page, showing publications ANANTH ANNAPRAGADA has written about Alzheimer Disease.
Connection Strength
1.133
-
A surrogate marker for very early-stage tau pathology is detectable by molecular magnetic resonance imaging. Theranostics. 2022; 12(12):5504-5521.
Score: 0.470
-
Intravenous delivery of targeted liposomes to amyloid-? pathology in APP/PSEN1 transgenic mice. PLoS One. 2012; 7(10):e48515.
Score: 0.240
-
Advances in nanoprobes for molecular MRI of Alzheimer's disease. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Mar-Apr; 16(2):e1946.
Score: 0.131
-
1-Indanone and 1,3-indandione Derivatives as Ligands for Misfolded a-Synuclein Aggregates. ChemMedChem. 2022 01 19; 17(2):e202100611.
Score: 0.112
-
Pre-clinical dose-ranging efficacy, pharmacokinetics, tissue biodistribution, and toxicity of a targeted contrast agent for MRI of amyloid deposition in Alzheimer's disease. Sci Rep. 2020 09 30; 10(1):16185.
Score: 0.104
-
Neuroimaging in Alzheimer's disease: preclinical challenges toward clinical efficacy. Transl Res. 2016 09; 175:37-53.
Score: 0.076